San Francisco-based Phil Inc, a technology platform for distributing and managing specialty prescription drugs, has raised $25 million in Series B funding. GreatPoint Ventures led the round with participation from Tarsadia Investments, Crosslink Capital and Uncork Capital.
Source: Press Release
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: